Cited by 49T-cell and B-cell ImmunologyChemokine receptors and signalingPsoriasis: Treatment and Pathogenesis

CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential

Open access
De Simone, Gabriele, Mazza, Emilia M C, Cassotta, Antonino, Davydov, Alexey N, Kuka, Mirela, Zanon, Veronica, De Paoli, Federica, Scamardella, Eloise +21 more·2019·The Journal of Immunology

Abstract

In mice, the ability of naive T (TN) cells to mount an effector response correlates with TCR sensitivity for self-derived Ags, which can be quantified indirectly by measuring surface expression levels of CD5. Equivalent findings have not been reported previously in humans. We identified two discrete subsets of human CD8+ TN cells, defined by the absence or presence of the chemokine receptor CXCR3. The more abundant CXCR3+ TN cell subset displayed an effector-like transcriptional profile and expressed TCRs with physicochemical characteristics indicative of enhanced interactions with peptide–HLA class I Ags. Moreover, CXCR3+ TN cells frequently produced IL-2 and TNF in response to nonspecific activation directly ex vivo and differentiated readily into Ag-specific effector cells in vitro. Comparative analyses further revealed that human CXCR3+ TN cells were transcriptionally equivalent to murine CXCR3+ TN cells, which expressed high levels of CD5. These findings provide support for the notion that effector differentiation is shaped by heterogeneity in the preimmune repertoire of human CD8+ T cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1901072

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The gating strategy shown in this section is applicable for analysis of conventional αβ CD8+ T cells in any kind of physiological or clinical setting.

    “The gating strategy shown in this section is applicable for analysis of conventional αβ CD8+ T cells in any kind of physiological or clinical setting [207, 208, 222].”

    From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [207]

    The Methods (Flow cytometry and cell sorting; page unavailable) describe a gating strategy, and Figure 1A in the Results shows it for naive human CD8+ T-cell subsets. The paper examines samples from healthy individuals and patients with head and neck cancer, but it does not establish that the citing document’s strategy applies to conventional αβ CD8+ T cells in any physiological or clinical setting. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 79 · Cited by 49

Authors
De Simone, G., Mazza, E. M. C., Cassotta, A., Davydov, A. N., Kuka, M., Zanon, V., De Paoli, F., Scamardella, E., Metsger, M., Roberto, A., Pilipow, K., Colombo, F. S., Tenedini, E., Tagliafico, E., Gattinoni, L., Mavilio, D., Peano, C., Price, D. A., Singh, S. P., Farber, J. M., Serra, V., Cucca, F., Ferrari, F., Orrù, V., Fiorillo, E., Iannacone, M., Chudakov, D. M., Sallusto, F., & Lugli, E.
Affiliations
  • Laboratory of Translational Immunology, Humanitas Clinical and Research Center , 20089 Rozzano, Milan ,
  • Humanitas University (IT)
  • ETH Zurich (CH)
  • Central European Institute of Technology (CZ)
  • Vita-Salute San Raffaele University (IT)
  • University of Modena and Reggio Emilia (IT)
  • University Hospital Regensburg (DE)
  • Cardiff University (GB)
  • National Institutes of Health (US)
  • Institute of Genetic and Biomedical Research (IT)
  • IFOM (IT)
Corresponding author
  • Zanon, Veronica
  • Scamardella, Eloise
  • Roberto, Alessandra
  • Pilipow, Karolina
  • Gattinoni, Luca
  • Lugli, Enrico
Venue
The Journal of Immunology
Published
2019-12
Volume
203
Issue
12
Pages
3179-3189
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2983661566
Cited by
49
References
79
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 14 · 2020: 5
FWCI
2.59
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
  • CNR ExploRA (submittedVersion, other-oa)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
  • National Science Foundation
  • Giovanni Armenise-Harvard Foundation
  • Emory University
  • University of Minnesota
  • Institute for Research in Biomedicine
  • Wellcome Trust (100326, 100326/Z/12/Z)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (149475, 100326)
  • Ministero della Salute (02347324, 82/2015, GR‐2011‐02347925)
  • Associazione Italiana per la Ricerca sul Cancro (19891)
  • Fondazione Italiana per la Ricerca sul Cancro
  • Ministry of Science and Higher Education of the Russian Federation
  • Helmut Horten Stiftung
  • Humanitas Research Hospital
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • H2020 European Research Council (640511, 725038)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
CXCR3, naive CD8+ T cells, effector differentiation, T cell receptor repertoire, chemokine receptors, CD5, interleukin-2, TNF-α, T cell heterogeneity, gene expression profiling
MeSH terms
Adult, Age Factors, Aged, Animals, Cell Differentiation, Cells, Cultured, Female, Humans, Immunologic Memory, Lymphocyte Activation, Male, Middle Aged, Biomarkers, Immunophenotyping, T-Lymphocyte Subsets, CD8-Positive T-Lymphocytes, Mice, Receptors, CXCR3, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review